| Financial Year |
March 31 2023 |
| Monetary Funds |
8,192,843,757.96 |
| Held-for-trading Financial Assets |
1,400,000,000.00 |
| Notes Receivable |
257,118,480.15 |
| Accounts Receivable |
668,113,367.12 |
| Advances to Suppliers |
179,347,330.82 |
| Other Receivables |
23,035,674.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
691,982,708.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,687,600.47 |
| Total Current Assets |
11,696,975,479.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,816,866.17 |
| Investment Properties |
-- |
| Fixed Assetes |
2,465,374,594.15 |
| Under-construction Projects |
1,728,888,735.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
415,167,818.70 |
| R&D expenses |
115,243.58 |
| Goodwill |
416,695,796.96 |
| Long-Term Deferred and Prepaid Expenses |
20,993,312.66 |
| Deferred Income Tax Assets |
38,716,267.64 |
| Other Non-Current Assets |
461,027,944.46 |
| Sub-Total of Non-Current Assets |
5,887,040,038.36 |
| Total Assets |
17,584,015,517.86 |
| Short-Term Loans |
1,579,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,229,351,173.08 |
| Accounts Payable |
420,568,377.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,586,833.05 |
| Taxes Payable |
53,399,125.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,547,993.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,944,187.80 |
| Other Current Liabilities |
4,686,438.02 |
| Sub-Total of Current Liabilities |
4,397,144,421.48 |
| Long-term Loans |
748,770,298.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,621,608.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,542,918.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
848,215,784.81 |
| Total Liabilities |
5,245,360,206.29 |
| Paid-In Capital(Or Share Stock) |
3,871,026,315.00 |
| Capital Surplus |
5,436,457,451.71 |
| Surplus Reserve |
250,314,656.49 |
| LESS:Treasury Stock |
502,999,610.86 |
| Undistributed Profits |
3,236,429,652.96 |
| Minority Stockholder's Interest |
56,669,908.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,281,985,402.73 |
| Owner's Equity（Stockholder's Equity） |
12,338,655,311.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,584,015,517.86 |
